BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29397827)

  • 1. [Value of CD, MPO, Ki-67 and C-MYC Positive Rate in the Pathological Tissues and C-MYC Gene of Patients with T-LBL/ALL for Predicting Prognosis].
    Wu Y; Tang HY; Ding YY; Pan XQ; Tan CM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):110-115. PubMed ID: 29397827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of C-myc expression in T-lymphoblastic lymphoma/leukemia and its relation with prognosis].
    Zhang Y; Li J; Xi Y; Bai W; Bai W; Sun R
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):571-7. PubMed ID: 26705181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C-MYC Gene and Protein Expression in Paraffin Wax of T Lymphoblastic Lymphoma and Leukemia Patients and Its Effect on the Prognosis].
    Zhang XD; He LM; Ma L; Chang ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):141-145. PubMed ID: 29397833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of microRNA-16 and bcl-2 expression in T lymphoblastic lymphoma/leukemia and its relation with prognosis].
    Li J; Li P; Wang JF; Xi YF
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):748-52. PubMed ID: 24447552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of chromosome 11q23 in T-ALL/LBL and their relation to prognosis.
    Wang JF; Li J; Xi YF; Bai W
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):375-80. PubMed ID: 22710816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mediastinal T lymphoblastic lymphoma/leukemia: clinicopathological and prognostic analyses of 61 cases].
    Gao XZ; Wei JG; Li SL; Han J; Wang GN; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):601-606. PubMed ID: 32486538
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma/leukemia].
    Yu B; Du JR; Xie JL; Yu R; Zheng XD; Zhu H; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):452-7. PubMed ID: 21055173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
    Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of CXCL12/CXCR4 expression in T-lymphoblastic lymphoma/leukemia].
    Yu ZZ; Xi YF; Li J; Bai WQ; Gao N; Bu P
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):838-843. PubMed ID: 28056298
    [No Abstract]   [Full Text] [Related]  

  • 12. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma.
    Gu Y; Pan Y; Meng B; Guan B; Fu K; Sun B; Zheng F
    Tumour Biol; 2013 Jun; 34(3):1441-50. PubMed ID: 23494176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinicopathological study of 96 cases of lymphoblastic lymphoma].
    Pan Y; Liu WP; Li JF; Zhang WY; Li FY; Lu XX; Li D; Li GD
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):218-22. PubMed ID: 15949264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features of T-lymphoblastic lymphoma with Langerhans cell histiocytosis in the same lymph node].
    Liu F; Rao HL; Guo N; Guo L; Lyu J; Hu WW; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):149-155. PubMed ID: 32074728
    [No Abstract]   [Full Text] [Related]  

  • 18. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
    Xi Y; Li J; Zhang P; Bai W; Gao N; Bai W; Zhang Y; Wu Y; Ning Y
    Exp Mol Pathol; 2015 Oct; 99(2):297-302. PubMed ID: 26231295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
    Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
    Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of costimulatory molecules B7H3 and B7H4 in T lymphoblastic lymphoma/leukemia and clinical significance].
    Zhang GZ; Li J; Bai WQ; Bu P; Wang HW; Xi YF
    Zhonghua Bing Li Xue Za Zhi; 2019 May; 48(5):352-357. PubMed ID: 31104673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.